NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Lyka Labs Limited (NSE: LYKALABS)

LYKALABS Technical Analysis
As on 1st Dec 2023 LYKALABS SHARE Price closed @ 126.60 and we RECOMMEND N/A for LONG-TERM with Stoploss of 0.00 & N/A for SHORT-TERM with Stoploss of 0.00 we also expect STOCK to react on Following IMPORTANT LEVELS.


Open 127.15 Change Price %
High 135.75 1 Day N/A N/A
Low 126.20 1 Week 0.00 0.00
Close 126.60 1 Month 0.00 0.00
Volume 127549 1 Year 0.00 0.00
52 Week High 0.00 | 52 Week Low 0.00
NSE INDIA Most Active Stocks
IDEA 13.25 1.53%
YESBANK 19.30 -0.26%
TV18BRDCST 48.00 11.37%
PNB 80.70 3.99%
RPOWER 20.85 -1.42%
NHPC 56.40 3.68%
JPPOWER 12.85 -1.91%
SUZLON 39.40 -3.31%
ZOMATO 116.30 -1.90%
GAIL 136.05 3.15%
NSE INDIA Top Gainers Stocks
BIL 284.85 19.23%
BIL 284.85 19.23%
BIL 284.85 19.23%
BIL 284.85 19.23%
BIL 284.85 19.23%
BIL 284.85 19.23%
BIL 284.85 19.23%
BIL 284.85 19.23%
SHALPAINTS 198.70 17.85%
DATAMATICS 740.05 16.78%
NSE INDIA Top Losers Stocks
WHIRLPOOL 1416.00 -9.88%
NIACL 231.25 -9.38%
GODHA 0.50 -9.09%
SMLISUZU 1410.15 -7.10%
TVSSRICHAK 4552.35 -5.58%
LCCINFOTEC 1.80 -5.26%
ORIENTCEM 246.85 -5.08%
COMPUSOFT 39.40 -4.95%
GANESHBE 162.05 -4.79%
ALPSINDUS 2.00 -4.76%
Daily Charts
Intraday Charts
Whats New @
Free Analysis
LYKALABS Important Levels Intraday
LYKALABS Target December 2023
4th UP Target0
3rd UP Target0
2nd UP Target0
1st UP Target0
1st DOWN Target0
2nd DOWN Target0
3rd DOWN Target0
4th DOWN Target0
LYKALABS Weekly Target
4th UP Target0.00
3rd UP Target0.00
2nd UP Target0.00
1st UP Target0.00
1st DOWN Target0.00
2nd DOWN Target0.00
3rd DOWN Target0.00
4th DOWN Target0.00
LYKALABS Target2023
4th UP Target0
3rd UP Target0
2nd UP Target0
1st UP Target0
1st DOWN Target0
2nd DOWN Target0
3rd DOWN Target0
4th DOWN Target0
LYKALABS Synopsis Technicals View
50 Day EMA Close is Above EMA 50 (Short Term)
100 Day EMA Close is Above EMA 100 (Mid Term) Bullish
200 Day EMA Close is Above EMA 200 (Long Term) Bullish
MACD (12 26 9) MACD Line is Less Then SIGNAL Line Bearish
RSI (14) RSI is Below 30 Over Sold
MFI (14) MFI is 22.98 Sideways
CCI (20) CCI is Below -100 Over Sold
WILLIAM %R (14) William %R is Below -80 Over Sold
ADX (14) ADX is Above 20 & +DI is Below -DI Down Trend
PSAR Stoploss For Long Buy 16.18
10 Day Avg Volume Traded 247.61 % More then 10 Day Average Volume
LYKALABS Other Details
Segment EQ
Market Capital 2685383936.00
Sector Healthcare
Industry Biotechnology
Offical website >
LYKALABS Latest News
Your Comments and Response on Lyka Labs Limited
LYKALABS Business Profile
Lyka Labs Limited engages in the manufacturing and sale of pharmaceutical formulations and active pharmaceutical ingredients across various therapeutic segments in India. It manufactures and sells various formulations, including emollient, topical steroid, antifungal agent, topical anti-bacterial, acne management, dermatological formulation, pain killer, anti-aging, cleansing lotion, hair care, anti-dandruff shampoo, sunscreen, anti-acne, cosmeceutical, anti-oxidant, proton pump inhibitor, anti-malarial, anti-bacterial, corticosteroid hormones, cephalosporin, dry powder injection, muscle relaxant, bone resorption inhibitor, anti-oxidant/liver disease, antibiotic, and lyophilized products. The company also provides contracted manufacturing services to various large pharmaceutical companies; and medical and technical assistance in the areas of manufacturing know how and manufacturing facilities, as well as technical data, such as molecule stability testing data, impurity profile, BA/BE clinical study data, etc. In addition, it provides products and services in therapeutic categories, such as intensive care, gastroenterology, anti-infective, anti-fungal, surgery care, cosmetologist, urology, wound care, and anesthesia, as well as deals in pharmaceutical products. Lyka Labs Limited offers its products in various formulations, including injections, creams, ointments, foams, gels, and lotions. Further, the company exports its products to Bangladesh, Combodia, Congo, Costa Rica, Peru, Romania, Russia, Sri Lanka, Sudan, Ukraine, Venezuela, and Vietnam. Lyka Labs Limited was incorporated in 1976 and is based in Mumbai, India. Address: Spencer Building, Mumbai, India, 400036
2005-2023 All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service